IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Addex Therapeutics LTD (ADXN)

CUSIP: 00654J206 | US | Healthcare · Biotechnology | Micro Cap | 12 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ATimothy Mark Dyer19,165,7149.0%+70,204Sep 2, 2026No 13F filer matched
13D/ATimothy Mark Dyer19,165,714
9.0% of class · Sep 2, 2026

Institutional Holders — Q3 2026

SBI Securities Co., Ltd.141
0.0% of portfolio›$389
StyleTurnoverLocationFiled
SBI Securities Co., Ltd.
141$3890.0%Agg GrowthLowTokyo, Mexico2026-10-22
+70,204
No 13F filer matched